openPR Logo
Press release

Amoxicillin Drugs Market Expected to Secure Notable Revenue Share during 2018-2028 // key player - JAMP Pharma Corporation, Novartis, Dr. Reddy's Laboratories, Sun Pharmaceuticals, Proficient Rx LP.

04-09-2019 09:34 AM CET | Health & Medicine

Press release from: Fact.MR

Amoxicillin Drugs Market Expected to Secure Notable Revenue

These dual and triple therapies are under clinical trials. The rising number of clinical trials to check the efficacy and effects of combination drugs with amoxicillin drugs is expected to drive the growth of amoxicillin drugs market in the forecast period. However, the most common adverse effects observed in clinical trials on combination drugs are diarrhea, vomiting, rash, and nausea. This may delay the marketing of combination drug in the market and may hamper the growth of Amoxicillin Drugs Market in the forecast period.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=3186

Amoxicillin drugs is a form of generic drugs of Amoxil branded drug commonly used in the treatment of bacterial infections. The Amoxicillin drugs fall under the drug class of β-lactam antibiotic. The increasing number of bacterial infections around the world, especially, in the developing and low-income countries is one of the reasons for the growing demand for Amoxicillin drugs and hence, boosting the growth of Amoxicillin drugs market. In the 1980s, the Food and Drug Administration (FDA) first approved amoxicillin drug. According to the surveillance released by the World Health Organization (WHO) showed that in high- and low-income countries increasing levels of antibiotic resistance to a number of serious bacterial infections. The Global Antimicrobial Surveillance System (GLASS) showed the occurrence of widespread antibiotic resistance among 500,000 people with a high risk of bacterial infections across 22 countries. However, Amoxicillin drugs suggested to not to take if the patients are allergic to any kind of penicillin antibiotic or amoxicillin. Some people do not know if they have infections or not, due to which patients may go through some serious complications. This may restrain the growth of Amoxicillin drugs market.

Amoxicillin Drugs: Market Dynamics

Today, there is a variety of branded and generic version of amoxicillin drugs are available in the market. Many drug manufacturers are manufacturing amoxicillin drugs and distributing in the market. The amoxicillin drugs can also use a combination with other drugs used to treat a bacterial infection such as triple therapy (amoxicillin/clarithromycin/ lansoprazole) and dual therapy (amoxicillin/lansoprazole). These dual and triple therapies are under clinical trials. The rising number of clinical trials to check the efficacy and effects of combination drugs with amoxicillin drugs is expected to drive the growth of amoxicillin drugs market in the forecast period. However, the most common adverse effects observed in clinical trials on combination drugs are diarrhea, vomiting, rash, and nausea. This may delay the marketing of combination drug in the market and may hamper the growth of amoxicillin drugs market in the forecast period.

Amoxicillin Drugs market: Overview

According to the World Health Organization (WHO), the most common resistant bacteria reported were Escherichia coli, Staphylococcus aureus, Streptococcus pneumonia, Salmonella spp. and Klebsiella pneumonia. Moreover, the variety of form is available for Amoxicillin drugs in the market such as tablets, capsule, suspensions, powder, and syrup. People who find difficulty in taking tablets or capsules, suspension, syrup or powered form amoxicillin drugs can be used. Suspension amoxicillin drugs are widely used by pediatric patients. Amoxicillin drugs are available in wide variety of distribution channels. These factors is expected to boost the growth of Amoxicillin drugs market.

Browse Full Report with TOC- https://www.factmr.com/report/3186/amoxicillin-drugs-market

North America is expected to show the highest revenue growth due to high investment in clinical trials and R&D spending, followed by Europe. The Amoxicillin Drugs market in the Asia-Pacific region is expected to show high CAGR growth due to large patient pool who are at high risk of bacterial infections because of poor sanitation, unsafe drinking water, and high population. Latin America and the Middle East & Africa are also at high risk of bacterial infections due unavailability of safe water.

Amoxicillin Drugs market: Key Players

Some of the key players present in global Amoxicillin drugs market are JAMP Pharma Corporation, Novartis, Dr. Reddy's Laboratories, Sun Pharmaceuticals, Proficient Rx LP., Sanis Health Inc, Nucare Pharmaceuticals,inc., Northwind Pharmaceuticals, A-S Medication Solutions, bryant ranch prepack and others

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain
The regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
The Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=3186

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Amoxicillin Drugs Market Expected to Secure Notable Revenue Share during 2018-2028 // key player - JAMP Pharma Corporation, Novartis, Dr. Reddy's Laboratories, Sun Pharmaceuticals, Proficient Rx LP. here

News-ID: 1694607 • Views:

More Releases from Fact.MR

Scalp Massage Combs Market to Reach USD 349.1 Million by 2036 at 6.5% CAGR as Scalp-First Beauty Routines Drive Global Demand
07-14-2026 | Health & Medicine
Fact.MR
Scalp Massage Combs Market to Reach USD 349.1 Million by 2036 at 6.5% CAGR as Sc …
Manual Combs Lead with 34.0% Share, Scalp-First Routines Account for 37.0%, and India Emerges as the Fastest-Growing Market at 8.0% CAGR The global Scalp Massage Combs Market is projected to increase from USD 186.0 million in 2026 to USD 349.1 million by 2036, expanding at a 6.5% CAGR during the forecast period. The market surpassed USD 178.5 million in 2025, supported by growing consumer interest in scalp-health routines, at-home treatment rituals,
Scalp Microbiome Sprays Market to Reach USD 963 Million by 2036 at 10.8% CAGR as Microbiome Science Reshapes Premium Scalp Care
07-14-2026 | Health & Medicine
Fact.MR
Scalp Microbiome Sprays Market to Reach USD 963 Million by 2036 at 10.8% CAGR as …
Prebiotic Support Leads with 34.0% Share, Prestige Beauty Commands 38.0%, and the United States Emerges as the Fastest-Growing Major Market at 11.4% CAGR The global Scalp Microbiome Sprays Market is projected to grow from USD 345 million in 2026 to USD 963 million by 2036, expanding at a 10.8% CAGR during the forecast period. The market reached USD 322 million in 2025 and continues to gain momentum as consumers increasingly adopt
Scalp Oil Balancers Market to Reach USD 1,860 Million Million by 2036 at 12.8% CAGR as Scalp-First Beauty Routines Transform Premium Haircare
07-14-2026 | Health & Medicine
Fact.MR
Scalp Oil Balancers Market to Reach USD 1,860 Million Million by 2036 at 12.8% C …
Zinc PCA Leads with 31.0% Market Share, Scalp-First Routines Hold 34.0%, and South Korea Emerges as the Fastest-Growing Market at 15.0% CAGR The global Scalp Oil Balancers Market is projected to grow from USD 557.0 million in 2026 to USD 1,860 million by 2036, registering a robust 12.8% CAGR during the forecast period. The market surpassed USD 514.2 million in 2025, reflecting rapidly growing consumer demand for cosmetic scalp treatments that
Anti-Flake Serum Sprays Market to Reach USD 2.3 Billion by 2036 at 11.1% CAGR, Driven by Scalp-First Beauty Routines and Active-Led Scalp Care Innovation
Anti-Flake Serum Sprays Market to Reach USD 2.3 Billion by 2036 at 11.1% CAGR, D …
Salicylic Acid Segment Holds 31.0% Share, Scalp-First Routines Lead with 38.0%, While South Korea Emerges as the Fastest-Growing Market at 12.4% CAGR The global Anti-Flake Serum Sprays Market is poised for substantial growth, with market value projected to increase from USD 0.8 billion in 2026 to USD 2.3 billion by 2036, expanding at a compound annual growth rate (CAGR) of 11.1% during the forecast period. The market had already surpassed USD

All 5 Releases


More Releases for Amoxicillin

Track Amoxicillin Trihydrate Price Index Historical and Forecast
Executive Summary The global Amoxicillin Trihydrate market has undergone significant fluctuations between 2024 and 2025, shaped by volatile demand cycles, shifting trade policies, supply-chain bottlenecks, and ongoing tariff uncertainty across major pharmaceutical manufacturing economies. Price movements across North America, APAC, and Europe have reflected a mix of structural and short-term forces-ranging from inventory overhangs and strategic stockpiling to port congestion, deflationary trends, and regulatory policy shifts. As of Q3 2025, Amoxicillin Trihydrate
Amoxicillin Market Trends That Will Shape the Next Decade: Insights from Innovat …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Amoxicillin Market Size By 2025? Witnessing consistent expansion lately, the market for amoxicillin is projected to increase its valuation from $4.74 billion in 2024 to reach $4.9 billion by 2025, reflecting a three-point-four percent compound annual growth rate across the forecast period. This upward trajectory
Rising Infectious Disease Prevalence Fuels Growth In Amoxicillin Market Driving …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Amoxicillin Market Size By 2025? In recent times, the amoxicillin market has expanded progressively. The market is projected to escalate from $4.74 billion in 2024 to $4.91 billion in 2025, with a compound annual growth rate (CAGR) of 3.7%. The historical growth of the market
Primary Catalyst Driving Amoxicillin Market Evolution in 2025: Rising Infectious …
How Are the key drivers contributing to the expansion of the amoxicillin market? The rise in instances of infectious diseases is predicted to stimulate the expansion of the amoxicillin market. These diseases, caused by harmful microorganisms like bacteria, viruses, fungi, or parasites, are on the rise due to factors such as international travel, resistance to antimicrobial treatments, changes in climate affecting disease carriers, and population density. Amoxicillin addresses infectious diseases by
Shaping the Amoxicillin Market in 2025: Innovative Treatment Approaches In The A …
How Big Is the Amoxicillin Market Expected to Be, and What Will Its Growth Rate Be? The size of the amoxicillin market has experienced consistent growth over the recent past. The market is projected to expand from $4.74 billion in 2024 to $4.91 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 3.7%. The past growth in the market can be traced back to factors such as improved knowledge
Amoxicillin Market Report 2024: Comprehensive Growth Analysis
The Business Research Company recently released a comprehensive report on the Global Amoxicillin Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of